The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID‐19 Patients: A Retrospective Cohort Study

On March 11, 2020, the World Health Organization declared its assessment of coronavirus disease 2019 (COVID‐19) as a global pandemic. However, specific anti‐severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) drugs are still under development, and patients are managed by multiple complement...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Chen, Wang, Cong, Wang, Hanxiang, Yang, Chao, Cai, Fei, Zeng, Fang, Cheng, Fang, Liu, Yihui, Zhou, Taotao, Deng, Bin, Vlodavsky, Israel, Li, Jin‐Ping, Zhang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719364/
https://www.ncbi.nlm.nih.gov/pubmed/32881340
http://dx.doi.org/10.1111/cts.12880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719364/
https://www.ncbi.nlm.nih.gov/pubmed/32881340
http://dx.doi.org/10.1111/cts.12880

Ejemplares similares